Status | Study |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Active, not recruiting |
Study Name: Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis Condition: Penile Cancer Squamous Carcinoma Date: 2016-05-24 Interventions: Drug: Chemotherapie TIP Paclitaxel, ifosfamide and cisplatine |
Recruiting |
Study Name: Study for the Evaluation of Efficacy of Pembrolizumab (MK-3475) in Patients With Rare Tumors Condition: Advanced Cancers Date: 2016-03-23 Interventions: Drug: Pembrolizumab 200 mg by |
Recruiting |
Study Name: Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Condition: Clear Cell Renal Cell Carcinoma Metastatic Malignant Neoplasm in the Bone Date: 2015-07-08 Interventions: Drug: Cabozantinib S-malate Gi |
Recruiting |
Study Name: HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA Condition: Human Papillomavirus-Related Carcinoma Human Papillomavirus Positive Oropharyngeal Carcinoma Date: 2015-02-25 Interventions: Biological: HPV Specific T Cells |
Completed |
Study Name: A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis Condition: Penile Neoplasm Date: 2014-10-30 Interventions: Drug: Cabazitaxel Six cycles of chemotherapy comprising: |
Terminated |
Study Name: Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) Condition: Penile Squamous Cell Carcinoma Stage IV Date: 2014-10-27 Interventions: Drug: Pazopanib Pazopanib 800m |
Not yet recruiting |
Study Name: International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) Condition: Squamous Cell Carcinoma of the Penis, Usual Type Date: 2014-09-23 Interventions: Procedure: ILND - Inguinal Lymph Node Dissection |
Active, not recruiting |
Study Name: A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP) Condition: Locally-advanced or Metastatic Penile Neoplasms Date: 2014-02-05 Interventions: Drug: Vinflunine All patients will receive on Day 1 of a 21 day cycle, vinflunine 320mg/m2 via intraveno |
Withdrawn |
Study Name: Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE) Condition: Squamous Cell Carcinoma of the Penis Date: 2013-12-05 Interventions: Drug: Cetuximab |